Public Health | November 24, 2021
Asian Development Bank to loan US $ 300 mn to improve India’s primary healthcare
The programme will be implemented across 13 states and benefit 256 min
The programme will be implemented across 13 states and benefit 256 min
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
.jpg)
Molbio Diagnostics has been the pioneer in providing access to molecular testing through its Truenat Real Time PCR platform. Sriram Natarajan, Director & CEO, of the company shares his experiences on the journey so far in an interview with Thomas C Thottathil
Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
Subscribe To Our Newsletter & Stay Updated
